HI
WST icon

Harbour Investments’s West Pharmaceutical WST Stock Holding History

Harbour Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.7K Buy
69
+17
+33% +$5.2K ﹤0.01% 2833
2026
Q1 		$13K Buy
52
+11
+27% +$2.74K ﹤0.01% 3123
2025
Q4 		$11.3K Buy
41
+2
+5% +$547 ﹤0.01% 2685
2025
Q3 		$10.2K Buy
39
+1
+3% +$243 ﹤0.01% 2677
2025
Q2 		$8.31K Buy
38
+5
+15% +$1.07K ﹤0.01% 2651
2025
Q1 		$7.39K Buy
33
+2
+6% +$551 ﹤0.01% 2660
2024
Q4 		$10.2K Sell
31
-1
-3% -$315 ﹤0.01% 2439
2024
Q3 		$9.61K Sell
32
-11
-26% -$3.37K ﹤0.01% 2377
2024
Q2 		$14.2K Buy
43
+11
+34% +$3.89K ﹤0.01% 2121
2024
Q1 		$12.7K Sell
32
-9
-22% -$3.33K ﹤0.01% 2138
2023
Q4 		$14.4K Sell
41
-3
-7% -$1.06K ﹤0.01% 2011
2023
Q3 		$16.5K Buy
44
+18
+69% +$6.96K ﹤0.01% 1826
2023
Q2 		$9.94K Buy
26
+2
+8% +$714 ﹤0.01% 2033
2023
Q1 		$8.31K Hold
24
– – ﹤0.01% 2099
2022
Q4 		$5.65K Hold
24
– – ﹤0.01% 2180
2022
Q3 		$7K Hold
24
– – ﹤0.01% 2087
2022
Q2 		$7K Buy
+24
New +$7.81K ﹤0.01% 2087
2021
Q4 		$11K Sell
24
-33
-58% -$14.2K ﹤0.01% 1908
2021
Q3 		$24K Buy
57
+29
+104% +$12.2K ﹤0.01% 2205
2021
Q2 		$10K Hold
28
– – ﹤0.01% 2754
2021
Q1 		$8K Buy
+28
New +$8.01K ﹤0.01% 2735

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Harbour Investments's WST Position: Q2 2026 in Review

Harbour Investments increased its West Pharmaceutical (WST) stake by 33% in Q2 2026, buying an estimated $5.2K and bringing the position to 69 shares worth $24.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2833.

Harbour Investments first reported a position in WST in Q1 2021 and has held it in 21 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Harbour Investments held 69 shares of West Pharmaceutical worth $24.7K as of Q2 2026.
  • Harbour Investments bought 17 West Pharmaceutical shares in Q2 2026, an estimated $5.2K.
  • West Pharmaceutical made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #2833 holding.
  • Harbour Investments first reported a position in West Pharmaceutical in Q1 2021 and has held it in 21 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.